March 25, 2020 / 9:39 PM / 5 days ago

BRIEF-Alector Inc - We Will Continue To Develop Al008 Globally

Alector Inc:

* ALECTOR ENTERS INTO A LICENSING AGREEMENT WITH INNOVENT BIOLOGICS TO DEVELOP AND COMMERCIALIZE AL008 IN ONCOLOGY INDICATIONS IN CHINA

* ALECTOR INC - WE WILL CONTINUE TO DEVELOP AL008 GLOBALLY Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below